Prosthesis with CoPXE couple.Prosthesis with CoC torque.
Prosthesis with CoPXE couple.: Prosthesis with a second-generation ceramic-on-highly cross-linked polyethylene (CoPXE) couple.
Prosthesis with CoC torque.: Prosthesis with ceramic-on-ceramic (CoC) torque.
Study summary
Interest of a highly cross-linked polyethylene acetabular component doped with vitamin E in total hip arthroplasty of the young and active subject.
Eligibility
Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria:
* Patient aged 18 to 65 years,
* Who have signed their consent to participate in the study,
* For whom an indication for total hip arthroplasty has been given
Exclusion Criteria:
* History of hip surgery
* Indication for a dual mobility prosthesis (obese patient, dynamic spino-pelvic anomaly)
* Hip dysplasia
* Inflammatory rheumatic disease or any other progressive concomitant condition that may impact the patient's vital or functional prognosis
* Sequelae of neurological disease or stroke
* Pregnant or breastfeeding women
* Mental deficiency or any other reason that may hinder the understanding or the strict application of the protocol
* Patient likely not to return for follow-up visits
* Patient already included in another therapeutic study protocol
* Patient under court protection, guardianship or curatorship.
Primary outcome measure(s)
five-year wear thickness of the two friction pairs — Year 5 The primary endpoint is the five-year wear thickness of the two friction pairs (CoPXE versus CoC) after total hip arthroplasty. Wear thickness is the measurement of the penetration of the femoral head into the acetabular component. This measurement will be performed on frontal pelvic radiographs centred on the pubic symphysis using the semi-automatic computer-assisted technique described by Martell
Trial sites (1)
Facility
City
Region
Status
Hôpital Privé Jean Mermoz
Lyon
France
Recruiting
More GCS Ramsay Santé pour l'Enseignement et la Recherche trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.